Earnings Data
Report Date
Nov 05, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
594.78Last Year’s EPS
911.34Same Quarter Last Year
Based on 0 Analysts Ratings
SK Biopharmaceuticals Co., Ltd. (KR:326030) Earnings, Revenues Date & History
KR:326030 Q2 2026 Earnings Report
KR:326030 Upcoming Earnings
SK Biopharmaceuticals Co., Ltd.'s next earnings date is estimated for November 5, 2026, based on past reporting schedules.
KR:326030 Earnings History
Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
Nov 05, 2026 | 2026 (Q3) | 911.34 | ― | ― | ― | ||
Aug 05, 2026 | 2026 (Q2) | 376.95 | 54.28% (+204.60) | ― | ― | ||
May 07, 2026 | 2026 (Q1) | 250.53 | 423.61% (+1061.26) | ― | ― | ||
Feb 06, 2026 | 2025 (Q4) | 2380.32 | -28.79% (-685.33) | ― | ― | ||
Nov 05, 2025 | 2025 (Q3) | 80.57 | 1031.12% (+830.77) | ― | ― | ||
Aug 05, 2025 | 2025 (Q2) | 313.61 | 20.20% (+63.34) | ― | ― | ||
May 09, 2025 | 2025 (Q1) | 123.86 | 102.27% (+126.67) | ― | ― | ||
Feb 06, 2025 | 2024 (Q4) | 111.73 | 2030.42% (+2268.59) | ― | ― | ||
Nov 08, 2024 | 2024 (Q3) | -235.08 | 134.27% (+315.65) | ― | ― | ||
Aug 08, 2024 | 2024 (Q2) | -298.03 | 205.23% (+611.64) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
KR:326030 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 05, 2026 | $79800.00 | $82000.00 | +2.76% |
May 07, 2026 | $98500.00 | $99600.00 | +1.12% |
Feb 06, 2026 | $111500.00 | $108500.00 | -2.69% |
Nov 05, 2025 | $120300.00 | $120600.00 | +0.25% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SK Biopharmaceuticals Co., Ltd. (KR:326030) report earnings?
SK Biopharmaceuticals Co., Ltd. (KR:326030) is schdueled to report earning on Nov 05, 2026, TBA (Confirmed).
What is SK Biopharmaceuticals Co., Ltd. (KR:326030) earnings time?
SK Biopharmaceuticals Co., Ltd. (KR:326030) earnings time is at Nov 05, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of SK Biopharmaceuticals Co., Ltd. stock?
The P/E ratio of SK Biopharmaceuticals Co., Ltd. is N/A.
What is KR:326030 EPS forecast?
KR:326030 EPS forecast for the fiscal quarter 2026 (Q3) is 594.78.